|
U.S. Glaucoma Pharmaceuticals MarketsPublished by: Frost & Sullivan Published: Feb. 1, 1999 - 154 Pages Table of Contents
AbstractAs the number of elderly in the United States continues to rise, so will the need for effective glaucoma treatment. This Frost & Sullivan report which resulted from 100 interviews of providers, manufacturers, and industry associations analyzes the markets for pilocarpine, adrenergic agonist, beta-blocking, carbonic anhydrase inhibitor, and prostaglandin drugs. By presenting market statistics and by evaluating market trends, this report offers readers a detailed guide to the industry. It examines R& D trends, identifies potential growth areas, and includes profiles of key industry participants.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||